Recital 5, Decision_act (EU) 2025/1805

In forcesince 11 Sep 2025

Following the adoption of the Biocidal Products Committee (BPC) opinion on 13 September 2023 [European Chemicals Agency opinion of 13 September 2023 on the Union authorisation of ‘LANXESS CMIT/MIT biocidal product family’, https://echa.europa.eu/opinions-on-union-authorisation.] of the related reference product family, including the draft Summary of Product Characteristics (‘SPC’), the applicant was requested to submit a revised version of the SPC of the same biocidal product family that was aligned with the SPC of the related reference product family (‘aligned SPC’) and a letter of access to the data supporting the authorisation of the related reference product family (‘reference product family data’).